【ChiCTR2300073698】Endoscopic Pilonidal Sinus Treatment (EPSiT) For Sacrococcygeal Pilonidal Sinus Disease: A Prospective Long-Term Study
ChiCTR2300073698
结束
/
/
/
2023-07-19
/
/
pilonidal sinus
Endoscopic Pilonidal Sinus Treatment (EPSiT) For Sacrococcygeal Pilonidal Sinus Disease: A Prospective Long-Term Study
Endoscopic Pilonidal Sinus Treatment (EPSiT) For Sacrococcygeal Pilonidal Sinus Disease: A Prospective Long-Term Study
The primary outcomes were duration of healing, post-operative morbidities, persistence of discharge and recurrence at 1-7 years (for cases enrolled in 2021 from 2015 respectively). The secondary outcomes were operative time, return to work, cosmetic results and patients satisfaction. Patients were observed for wound healing and discharge on follow up in OPD at 1, 3, 6 and 24 weeks. They were further followed up every year through telephonic survey for persistence or recurrence of symptoms. Patients satisfaction was assessed according to 36- Item Short Form Survey (SF-36) questionnaire filled at admission and then at 6 weeks after the surgery
单臂
探索性研究/预试验
N/A
/
nil
/
67
/
2014-03-01
2023-03-16
/
All patients presenting to the Outpatients with pilonidal sinus with or without abscess will be included in the study;
请登录查看Only failure to give consent will be excluded;
请登录查看Shifa international hospital
/
Shifa international hospital的其他临床试验
shifa college of medicine, shifa tameer e millat university islamabad的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

